NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/08/2023
Voltar para busca
Dado oficial do USPTO
CIGNA SPECIALTY CARE OPTIONS PLUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CIGNA SPECIALTY CARE OPTIONS PLUS
ST13
US500000097216976Classe
35, 36, 44
Pedido
97216976
Registro
7152167
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
29/08/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 44
Data de depósito
13/01/2022
Data de registro
29/08/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/08/2023
Última transação
29/08/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/02/2022
Primeiro uso no comércio
01/02/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Wilmington, DE, US
Examinador
AREY, BRANDON LEON
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cigna Intellectual Property, Inc.
Representantes
Cigna Intellectual Property, Inc.
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Cost management for the medical benefit drug plans of other in the field of pharmaceuticals; business servicesadministration services in the field of healthcare; consulting services regarding healthcare costs; Drug utilization review services and medical formulary cost management services; medical drug cost management services; in-network provider advisory and consultancy servicesstrategic business analysis and business advice in the field of medical insurance regarding medical benefit specialty pharmaceuticals; cost management for the health care medical benefit plans for others management; business data analysis regarding health care benefit plan end-user behavior and health care benefit plan; healthcare user behavior; market study and analysis of healthcarehealthcare benefitsmedical drug benefits effecting health behavior change and choice at the patient level; administration of employee benefit plans concerning medical drug benefit plans; cost management for pharmaceutical and drug health care plan benefit servicestrackingmonitoringassessinganalyzing information and statistics regarding patient prescription drug use and healthcare habits to identify potential cost savings
Classe 36
Pharmaceutical and medical drug benefit management services; pharmaceutical and medical drug benefit management consulting services; medical benefit management services concerning insurance; advisory services and consultancy regarding medical insurance healthcare benefitsin-network coveragepharmaceutical and medical drug benefits; provision of information and analysis in the fields of healthcare insurance plan benefits; pharmaceutical and medical drug health care benefit coverage plans servicesproviding insurance underwriting and claims administration of pharmaceutical and medical drug plans for qualified beneficiaries; administration of pharmaceutical and medical drug benefit plans concerning insurance; pharmaceutical and medical drug benefit management services concerning insurancetrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsall to identify clinical benefits; pharmaceutical and medical drug healthcare benefit plan coverages servicesproviding information to patients regarding in-network services in the fields of disease management programs and chronic conditions
Classe 44
Advisory services and consultancy regarding healthcare; healthcare serviceswellness and disease management programs for patients; healthcare servicesdisease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication complianceproviding healthcare and medical information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcaremedical drugs; providing information in the field of healthcare to medical benefit management services clientsconsultants and brokers
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/08/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/07/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
26/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/07/2023
IUAF
USE AMENDMENT FILED
03/07/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/07/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2022
PUBO
PUBLISHED FOR OPPOSITION
08/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2022
GNRT
NON-FINAL ACTION E-MAILED
05/07/2022
CNRT
NON-FINAL ACTION WRITTEN
05/07/2022
DOCK
ASSIGNED TO EXAMINER
23/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/01/2022
NWAP
NEW APPLICATION ENTERED
17/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CIGNA SPECIALTY CARE OPTIONS PLUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.